PTC Therapeutics

$42.97
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.11 (0.26%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell PTCT and other stocks, options, ETFs, and crypto commission-free!

About PTCT

PTC Therapeutics, Inc. Common Stock, also called PTC Therapeutics, is a biopharmaceutical company, which engages in the discovery and commercialization of clinically-differentiated medicines. Read More It focuses on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology. The company was founded by Allan Steven Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.

Employees
517
Headquarters
South Plainfield, New Jersey
Founded
1998
Market Cap
2.53B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
378.53K
High Today
$43.69
Low Today
$42.19
Open Price
$42.19
Volume
165.66K
52 Week High
$48.99
52 Week Low
$27.53

Collections

PTCT Earnings

-$1.29
-$0.85
-$0.41
$0.03
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 5, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.